1094 related articles for article (PubMed ID: 11421505)
1. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
Eiser NM; Phillips C; Wooler PA
Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
[TBL] [Abstract][Full Text] [Related]
2. The role of domiciliary nebulizers in managing patients with severe COPD.
Eiser N; Angus K; McHale S
Respir Med; 2001 Apr; 95(4):265-74. PubMed ID: 11316108
[TBL] [Abstract][Full Text] [Related]
3. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
[TBL] [Abstract][Full Text] [Related]
4. Dry powder ipratropium bromide is as safe and effective as metered-dose inhaler formulation: a cumulative dose-response study in chronic obstructive pulmonary disease patients.
Cuvelier A; Muir JF; Benhamou D; Weitzenblum E; Zuck P; Delacenserie R; Taytard A; Iacono P
Respir Care; 2002 Feb; 47(2):159-66. PubMed ID: 11812272
[TBL] [Abstract][Full Text] [Related]
5. [Effect of ipratropium bromide on lung dynamic hyperinflation in patients with chronic obstructive lung disease].
Jorquera J; Díaz O; Lisboa C
Rev Med Chil; 2003 Jun; 131(6):605-12. PubMed ID: 12942587
[TBL] [Abstract][Full Text] [Related]
6. Quality of life measurements and bronchodilator responsiveness in prescribing nebulizer therapy in COPD.
Brophy C; Kastelik J; Gardiner E; Greenstone M
Chron Respir Dis; 2008; 5(1):13-8. PubMed ID: 18303097
[TBL] [Abstract][Full Text] [Related]
7. Randomized controlled trial of salbutamol aerosol therapy via metered dose inhaler-spacer vs. jet nebulizer in young children with wheezing.
Deerojanawong J; Manuyakorn W; Prapphal N; Harnruthakorn C; Sritippayawan S; Samransamruajkit R
Pediatr Pulmonol; 2005 May; 39(5):466-72. PubMed ID: 15786440
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
[TBL] [Abstract][Full Text] [Related]
9. A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease.
Balkissoon R; Make B
COPD; 2008 Aug; 5(4):221-7. PubMed ID: 18671147
[TBL] [Abstract][Full Text] [Related]
10. Bronchodilator therapy with metered-dose inhaler and spacer versus nebulizer in mechanically ventilated patients: comparison of magnitude and duration of response.
Duarte AG; Momii K; Bidani A
Respir Care; 2000 Jul; 45(7):817-23. PubMed ID: 10926377
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of tiotropium inhalation capsules and ipratropium metered dose inhaler in a randomized, double-blind, double-dummy, efficacy and safety study in patients with chronic obstructive pulmonary disease].
Zheng JP; Kang J; Cai BQ; Zhou X; Cao ZL; Bai CX; Zhong NS
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jun; 29(6):363-7. PubMed ID: 17045014
[TBL] [Abstract][Full Text] [Related]
12. Improved delivery of ipratropium bromide using Respimat (a new soft mist inhaler) compared with a conventional metered dose inhaler: cumulative dose response study in patients with COPD.
Iacono P; Velicitat P; Guemas E; Leclerc V; Thébault JJ
Respir Med; 2000 May; 94(5):490-5. PubMed ID: 10868713
[TBL] [Abstract][Full Text] [Related]
13. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ
Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
[TBL] [Abstract][Full Text] [Related]
14. Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease.
Ikeda A; Nishimura K; Koyama H; Tsukino M; Mishima M; Izumi T
Thorax; 1996 Jan; 51(1):48-53. PubMed ID: 8658369
[TBL] [Abstract][Full Text] [Related]
15. Clearance of lung secretions in patients with chronic bronchitis: effect of terbutaline and ipratropium bromide aerosols.
Pavia D; Bateman JR; Sheahan NF; Clarke SW
Eur J Respir Dis; 1980 Oct; 61(5):245-53. PubMed ID: 6451446
[TBL] [Abstract][Full Text] [Related]
16. A randomized study of tiotropium Respimat Soft Mist inhaler vs. ipratropium pMDI in COPD.
Voshaar T; Lapidus R; Maleki-Yazdi R; Timmer W; Rubin E; Lowe L; Bateman E
Respir Med; 2008 Jan; 102(1):32-41. PubMed ID: 17996436
[TBL] [Abstract][Full Text] [Related]
17. Improvement of inhaler efficacy by home-made spacer.
Sritara P; Janvitayanuchit S
J Med Assoc Thai; 1993 Dec; 76(12):693-7. PubMed ID: 7798822
[TBL] [Abstract][Full Text] [Related]
18. Dose potency relationship of terbutaline inhaled via Turbuhaler or via a pressurized metered dose inhaler.
Ekström T; Andersson AC; Skedinger M; Lindbladh C; Ståhl E
Ann Allergy Asthma Immunol; 1995 Apr; 74(4):328-32. PubMed ID: 7719894
[TBL] [Abstract][Full Text] [Related]
19. Additive benefits of tiotropium in COPD patients treated with long-acting beta agonists and corticosteroids.
Perng DW; Wu CC; Su KC; Lee YC; Perng RP; Tao CW
Respirology; 2006 Sep; 11(5):598-602. PubMed ID: 16916333
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of ipratropium bromide plus fenoterol inhaled via Respimat Soft Mist Inhaler vs. a conventional metered dose inhaler plus spacer in children with asthma.
von Berg A; Jeena PM; Soemantri PA; Vertruyen A; Schmidt P; Gerken F; Razzouk H
Pediatr Pulmonol; 2004 Mar; 37(3):264-72. PubMed ID: 14966821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
